EFFECTS ON THE REPRODUCTIVE SYSTEM OF DECEASED PREGNANT WOMEN FROM SARS-COV-2
Keywords:
COVID-19, cytokine storm, the uterus of the ovaries SARS-CoV-2, follicular granulosa cells.Abstract
Currently, the most urgent problem is the infection caused by the new coronavirus SARS-COV-2 and declared a pandemic by WHO on March 11, 20205. One of the risk groups are pregnant women, so doctors around the world are increasingly paying attention to the analysis of the impact of this infection on the course of pregnancy, childbirth and perinatal outcomes. Data on 100,000 pregnant women included in a systematic review of foreign literature showed the possibility of vertical transmission in 5.3% and the birth rate of COVID-positive newborns in 8% of cases. The most frequent complications of perinatal outcomes are fetal distress syndrome (26.5-30.0%), low birth weight (25.0%), neonatal asphyxia (1.4%)2. Hospitalization of children in the intensive care unit is required in 43% of cases, and perinatal mortality is 0.35-2.2%.
References
Aghaamoo S, Ghods K, Rahmanian M. Pregnant women with COVID-19: the placental involvement and consequences. J Mol Histol. 2021 Jun;52(3):427-435. doi:10.1007/s10735-021-09970-4. Epub 2021 Apr 19. PMID: 33871721; PMCID: PMC8053892.
Cornish EF, Filipovic I, Åsenius F, Williams DJ, McDonnell T. Innate Immune Responses to Acute Viral Infection During Pregnancy. Front Immunol. 2020 Sep 30;11:572567. doi: 10.3389/fimmu.2020.572567. PMID: 33101294; PMCID: PMC7556209.
Dilbaz B. Are women with polycystic ovary syndrome more vulnerable to COVID-19 infection? Turk J Obstet Gynecol. 2021 Sep 27;18(3):221-223. doi:10.4274/tjod.galenos.2021.05014. PMID: 34580749; PMCID: PMC8480216.
Herrero Y, Pascuali N, Velázquez C, Oubiña G, Hauk V, de Zúñiga I, Peña MG, Martínez G, Lavolpe M, Veiga F, Neuspiller F, Abramovich D, Scotti L, Parborell F. SARS-CoV-2 infection negatively affects ovarian function in ART patients. Biochim Biophys Acta Mol Basis Dis. 2022 Jan 1;1868(1):166295. doi:10.1016/j.bbadis.2021.166295. Epub 2021 Oct 27. PMID: 34718118; PMC
World Health Organisation Interim guidance: Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. V1.2. 21 April 2020. Available at: https://www.who.int/publications-detail/clinicalmanagement-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspectedID:PMC8550892.
